89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study

Clinical trial NCT03849118 · COMPLETED

Trial details

NCT number: NCT03849118
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma

Start date: 2019-08-15
Primary completion: 2022-10-20
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.